academic article

• Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer..  Lung cancer (Amsterdam, Netherlands).  47:253-259. 2005
• The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel..  Cancer.  98:779-788. 2003